Renaissance Technologies
VTGN icon

Renaissance Technologies’s VistaGen Therapeutics VTGN Stock Holding History

Renaissance Technologies’s Portfolio VTGN Stock Details VTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$165K Buy
730,500
+439,200
+151% +$265K ﹤0.01% 2919
2026
Q1 		$166K Buy
291,300
+130,509
+81% +$79.3K ﹤0.01% 2946
2025
Q4 		$106K Sell
160,791
-261,221
-62% -$944K ﹤0.01% 2998
2025
Q3 		$1.5M Buy
422,012
+381,512
+942% +$1.14M ﹤0.01% 2258
2025
Q2 		$81K Buy
40,500
+15,700
+63% +$35.7K ﹤0.01% 3332
2025
Q1 		$62K Sell
24,800
-58,900
-70% -$167K ﹤0.01% 3267
2024
Q4 		$247K Sell
83,700
-106,900
-56% -$301K ﹤0.01% 3102
2024
Q3 		$574K Buy
190,600
+125,700
+194% +$429K ﹤0.01% 2726
2024
Q2 		$226K Sell
64,900
-44,900
-41% -$194K ﹤0.01% 3006
2024
Q1 		$580K Buy
+109,800
New +$528K ﹤0.01% 2801
2023
Q1 		– Sell
-3,493
Closed -$11K – 4440
2022
Q4 		$11K Sell
3,493
-121,919
-97% -$459K ﹤0.01% 4032
2022
Q3 		$572K Buy
125,412
+97,725
+353% +$969K ﹤0.01% 2848
2022
Q2 		$731K Sell
27,687
-11,596
-30% -$409K ﹤0.01% 2909
2022
Q1 		$1.46M Buy
+39,283
New +$1.71M ﹤0.01% 2455
2021
Q3 		– Sell
-3,421
Closed -$323K – 3880
2021
Q2 		$323K Buy
+3,421
New +$253K ﹤0.01% 3123
2021
Q1 		– Sell
-27,833
Closed -$1.62M – 3748
2020
Q4 		$1.62M Buy
27,833
+23,700
+573% +$605K ﹤0.01% 2251
2020
Q3 		$86K Buy
4,133
+3,735
+938% +$77.3K ﹤0.01% 3232
2020
Q2 		$6K Buy
+398
New +$5.44K ﹤0.01% 3384

Other funds holding VTGN

CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
LM
Luminus Management Houston, Texas $146M AUM 27.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies's VTGN Position: Q2 2026 in Review

Renaissance Technologies increased its VistaGen Therapeutics (VTGN) stake by 151% in Q2 2026, buying an estimated $265K and bringing the position to 730,500 shares worth $165K. The position accounts for ﹤0.01% of the portfolio, ranked #2919.

Renaissance Technologies first reported a position in VTGN in Q2 2020 and has held it in 18 quarters since. The position peaked at $1.62M in Q4 2020. 48 funds tracked by Wall St. Rank hold VTGN as of Q2 2026.

  • Renaissance Technologies held 730,500 shares of VistaGen Therapeutics worth $165K as of Q2 2026.
  • Renaissance Technologies bought 439,200 VistaGen Therapeutics shares in Q2 2026, an estimated $265K.
  • VistaGen Therapeutics made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2919 holding.
  • Renaissance Technologies first reported a position in VistaGen Therapeutics in Q2 2020 and has held it in 18 quarters since.
  • Renaissance Technologies's VistaGen Therapeutics position peaked at $1.62M in Q4 2020.
  • 48 funds tracked by Wall St. Rank held VistaGen Therapeutics as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.